IRIS
PELUSO, ANNA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 369
EU - Europa 148
NA - Nord America 87
SA - Sud America 69
AF - Africa 3
Totale 676
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 134
CN - Cina 99
SG - Singapore 75
US - Stati Uniti d'America 70
KR - Corea 64
IL - Israele 60
BR - Brasile 54
VN - Vietnam 42
HK - Hong Kong 17
MX - Messico 17
AR - Argentina 7
DE - Germania 6
BD - Bangladesh 5
ID - Indonesia 4
EC - Ecuador 3
RU - Federazione Russa 3
EG - Egitto 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
IN - India 1
JP - Giappone 1
MA - Marocco 1
NL - Olanda 1
PE - Perù 1
PL - Polonia 1
PY - Paraguay 1
SE - Svezia 1
VE - Venezuela 1
Totale 676
Salva come PNG Salva come JPEG
Città #
Singapore 74
Chicago 64
Pescara 64
Seoul 64
Rome 60
Tel Aviv 60
Hong Kong 17
Mexico City 14
Beijing 13
Ho Chi Minh City 13
Hanoi 7
Milan 4
Brasília 3
Hangzhou 3
Belo Horizonte 2
Bắc Ninh 2
Can Tho 2
Curitiba 2
Da Nang 2
Guayaquil 2
Haiphong 2
Nam Định 2
Naples 2
Osasco 2
Recife 2
Ribeirão Preto 2
Salvador 2
São Paulo 2
Thái Nguyên 2
Ajman 1
Al Mansurah 1
Allen 1
Americana 1
Barra do Piraí 1
Biên Hòa 1
Brumadinho 1
Campina Grande 1
Campinas 1
Cananéia 1
Canoas 1
Cape Girardeau 1
Carapicuíba 1
Casablanca 1
Castanhal 1
Ciudad Evita 1
Ciudad Guayana 1
Clorinda 1
Cuenca 1
Cusco 1
Dhaka 1
Diamantino 1
Dokki 1
Dom Eliseu 1
Dębica 1
Formiga 1
Formosa 1
Guajeru 1
Hidrolândia 1
Hòa Bình 1
Ibiúna 1
Itajaí 1
Jaguaquara 1
Joinville 1
La Banda 1
Lontras 1
Luis Eduardo Magalhães 1
Luque 1
Mongaguá 1
Mumbai 1
Naucalpan 1
Nha Trang 1
Ninh Bình 1
Oliveira 1
Osório 1
Palmeira 1
Pekanbaru 1
Petrolina 1
Petrópolis 1
Phủ Lý 1
Piracicaba 1
Piracuruca 1
Porto Alegre 1
Quilmes 1
Quixadá 1
Quận Bình Thạnh 1
Rimini 1
San Luis Potosí City 1
Santa Fe 1
Santiago 1
Santiago de Cali 1
Sevastopol 1
Shanghai 1
Solidaridad 1
Sorocaba 1
St Petersburg 1
São Gonçalo 1
São José dos Campos 1
São João da Boa Vista 1
São Lourenço 1
Thái Bình 1
Totale 561
Salva come PNG Salva come JPEG
Nome #
Risorse genetiche di organismi utili per il miglioramento di specie di interesse agrario e per un'agricoltura sostenibile 21
Frequenza delle mutazioni c-kit in pazienti affetti da Leucemia mieloide acuta (LAM) caratterizzata da alterazioni del gene del core binding factor (CBF) 14
Ligh chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis 14
Caratterizzazione dei ceppi di Rhizobium spp. Simbionti di leguminose selvatiche e coltivate del climax mediterraneo 14
Acute and Chronic Ph+ leukemias: differential leukemogenesis pathways translate into different clinical needs 14
The A1059E mutation in Jak2 gene was detected in patients with Idiopathic Erithrocytosis secondary to Acute Lymphoblastic Leukemia 14
Attivazione di una immunità specifica per PRAME mediante l'utilizzo di una libreria peptidica in pazienti affetti da patologie ematologiche 13
Heat Shock Protein 90 (HSP90) regulates the expression of preferentially Expressed Antigen of Melanoma (PRAME) in cell lines derived from patients with Chronic Myeloid Leukemia 13
A particular mutational status in a Chronic Myeloid Leukemia patient treated with different tyrosine-Kinase inhibitors 13
Clinical relevance in Chronic Myeloid Leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL 13
Evaluation of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies 13
Clinical outcome of Chronic Myeloid Leukemia (CML) patients with deletion and Insertion events (DI) in the Tyrosine Kinase Domain of Bcr-Abl 13
Mesenchymal stem cell (MSC) derived from bone marrow (BM) of patients with Chronic Myelogenous Leukemia protect Ph+ leukemic cells from TKI induced apoptosis 13
Characterization of Rhizobium spp.strains symbionts of wild and cultivated legumes of the Mediterranean climax 12
Clonal evolution in a case of hepatosplenic T cell lymphoma 12
Use of nodulation pattern, stress tolerance, nodC gene amplification, RAPD-PCR and RFLP-16S rDNA analysis to discriminate genotypes of Rhizobium leguminosarum biovar viciae 12
Increasing BCR-ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia 12
Increasing BCR-.ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia 12
First case of KIT Ser715del and Jak2 Val617Val mutation in systemic mastocytosis with associated essential thrombocythemia 12
Highly Sensitive Detection of BCR-ABL Kinase Domain Mutations in CML patients by an Ultra-Deep Sequencing Approach 12
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 12
Characterization of proteins involved in the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia 12
Characterization of proteins involved in the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia 12
Decreased level of SHP-1 provides an additive survival advantage to Philadelphia Chromosome-positive (Ph+) cells derived from patients with Chronic Myeloid Leukemia (CML) and account for resistance to Imatinib (Ima) treatment 12
Unravelling the Mechanism of Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a Proteomic Approach 12
Diversity of Rhizobium leguminosa rum biovar viciae strains nodulating wild and crop legumes in central-southern Italy 12
Clinical relevance in Chronic Myeloid Leukemia of deletion and insertion events in tyrosine kynase domain of BCR-ABL 12
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 12
The expression of shp-1 andSHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 12
Reduced levels of SHP1 provides an additive survival advantage to the Ph+ cells of CML patients and may account for resistance to Ima treatment 12
Evalution of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies 12
Deletion and insertion events in tyrosine Kinase domain of BCR-ABL is a common phenomenon in Chronic Myeloid Leukemia 12
The activity of tyrosine Kinase inhibitors on T-cell proliferation and activation 12
Unravelling the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a proteomic approach 12
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 12
L'ATTIVITÀ DEGLI INIBITORI DI TIROSINA KINASI (TKI) SULLA PROLIFERAZIONE E L'ATTIVAZIONE DELLE CELLULE T 11
Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis 11
First case of S716del mutation in the cKIT gene and V617V mutation in Jak2 gene in a patient affected by essential thrombocytopenia associated to systemic mastocytosis 11
Decrease level of SHP1 provides an additive survival advantage to Philadelphia chromosome-positive (Ph+) cells derived from patients with chronic myeloid leukemia (CML) and account for resistance to Imatinib (Ima) treatment 11
The dynamics of ABL mutations onset in Ph+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate 11
High-avidity cytotoxic lymphocytes specific for a new peotide derived from Preferentially expressed Antigen of Melanoma (PRAME) can target leukemia precursor cells 11
Immunoglobulin heavy and light chains and T-cell receptor beta and gamma chains PCR assessment on cytological samples. A study comparing FTA cards and cryopreserved lymph node fine-needle cytology 11
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies, including chronic myelogenous leukemia 11
Cytopathology diagnosis of the thyroidal nodule: a review 11
cKIT mutations frequency detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangement 11
Flow cytometric immunophenotypic and molecular profiles and follow-up in a case of gamma-delta hepatosplenic T-cell Lymphoma 11
Biochimica ematologica in Biochimica del plasma e sistema ematopoietico 10
Frequencies of cKIT mutations detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangements 10
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) 10
Primo caso di trombocitemia essenziale (TE) associate a mastocitosi ossea con mutazione S715del del gene c-KIT e V616V del gene JAK2 10
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients 10
Reduced levels of SHP1 provides an additive serviva advantage to the PH- cells of CML patients and may account for resistance to IMA treatment 10
Light chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis 10
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukaemia 10
The constitutive activated V617F Janus Kinase 2 (JAK2) induces centrosome abnormalities 10
SHP1 expression accounts for resistance to Imatinib treatment in Philadelphia chromosome-positive cells derived from patients with Chronic Myeloid Leukemia 10
Clinical relevance in chronic myeloid leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL 10
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pre-treatment Predictor of Major Molecular Response Achievement in CML Patients 10
The dynamics of ABL mutations onset in PH+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate 9
UNA BASSA ESPRESSIONE DELLA FOSFATASI SHP-1 CORRELA CON LA RESI-STENZA AL TRATTAMENTO CON INIBITORI DELLE TIROSIN KINASI IN PAZIENTIAFFETTI DA LEUCEMIA MIELOIDE CRONICA 9
Effectiveness of interferon alpha therapy in essential thrombocythemia 9
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies. Including chronic myelogenous leukemia 9
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 9
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) 8
Totale 740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025329 0 0 0 64 2 4 5 126 14 0 110 4
2025/2026411 62 69 194 86 0 0 0 0 0 0 0 0
Totale 740